Shiseido is handing one of its longest-running China businesses to a venture capital firm. The Japanese beauty group announced on November 17 that it will transfer all equity and operations of Shiseido Liyuan Cosmetics Co., Ltd., the company behind the Aupres brand, to an investor consortium led by IDG Capital.
The deal includes the unit's Beijing factory and production equipment, and both sides have already signed the relevant agreements, according to a report published by 36Kr and originally written by the WeChat outlet Qingyan.
For Aupres, a brand sold exclusively in China for more than 30 years, the sale marks the end of its time inside the Shiseido group and the start of life as an independent company.
A Turbulent Year for a Long-Running Joint Venture
Shiseido Liyuan was founded in 1991 as a joint venture between Shiseido and Beijing Liyuan Co., Ltd., a company backed by state-owned capital. That partnership unwound earlier this year.
In June, Beijing Liyuan put its 35% stake up for sale with a reserve price of 199.5 million yuan. By September, the stake had passed to Shiseido (China) Investment Co., Ltd. for that same amount, leaving the brand without any Chinese state-owned shareholders.
Disclosures at the time showed the business had lost close to 100 million yuan between the start of 2025 and May 2026, prompting speculation that Shiseido would restructure the brand. Aupres still appeared alongside Shiseido at the 9th China International Import Expo in early November, showcasing its Black Genie product line.
How the Deal Is Structured
Shiseido's entire holding will be split among three newly registered entities. A 95% stake goes to a special purpose vehicle set up by an IDG-managed fund, with Sunrise Winning Limited holding 80.66% and Zhuhai Pulai Management Consulting Partnership holding 14.34%.
The remaining 5% goes to Shanghai Puzhiyuan Enterprise Management Partnership, an entity formed by Shiseido Liyuan's incoming management team. The transfer is expected to close between the fourth quarter of 2026 and the first quarter of 2027.
Aupres will be run by a new leadership team with experience in beauty brand management and business turnarounds. That could mean a change at the top for the brand, which is currently led by general manager Kaname Sasaki, who has often promoted it publicly as the president of Aupres.
Shiseido Promises Transitional Support
To protect product continuity, Shiseido will license the intellectual property needed to run the business and keep helping with new product development for a defined period after the sale. It will also offer technical assistance and continue supplying raw materials and selected products.
Shiseido China said the Aupres business is operating normally and that it will work with IDG to support employees, consumers and partners during the handover. The company said it expects IDG to drive sustainable growth and lift the brand's value. Whether Aupres can build its own product pipeline without the group's deep research base remains an open question.
An Unusual Move for IDG Capital
IDG traces its roots to 1964, when Patrick J. McGovern started the company with 5,000 US dollars. In 1993 it launched PTV-China, the first foreign-invested venture fund in China, and in 1999 IDG Capital became an independent partnership that went on to back early Chinese internet companies such as Tencent, Baidu and Ctrip.
The firm has long been active in cosmetics. An industry white paper counted 17 IDG investments in China's cosmetics sector between 2007 and 2017. Its portfolio has included Meila Beauty, Afu Essential Oil, Helijia, Girlcult, WOW COLOUR, Protogen Biotech, Femooi and Ruidu, and in December 2025 it led the first strategic round for dermatology-focused brand FulQun.
Those deals were mostly minority or lead investments that did not require running the companies. Taking full control of Aupres puts IDG in the role of operator, a significant test of its brand management capabilities.
Why Shiseido Is Letting Go
Shiseido described the sale as part of a broader effort to reshape its China brand portfolio and focus resources on key brands and growth areas. It cited rapid e-commerce growth, shifting consumer behavior and new competitors as forces changing the Chinese market, while stressing that China remains one of its most important markets.
Its 2030 Medium-Term Strategy, released last November, prioritizes high-growth categories such as skincare and sun care and sorts brands into core, future, emerging and transforming groups. In the third quarter, emerging brands BAUM and d program grew while Drunk Elephant posted a double-digit decline.
The streamlining appears to be helping. In the first three quarters of the year, Shiseido's net sales rose 7% to 741.1 billion yen, while core operating profit jumped 124% to 67.5 billion yen.
What the Sale Signals for Investors and Brand Builders
The deal highlights a pattern in which global groups prune legacy brands that once thrived in department stores but now struggle against digital-first rivals. Those brands can become turnaround opportunities for financial investors willing to take on operational risk.
For IDG, success will depend on whether it can reposition Aupres for today's Chinese consumers without the parent company's resources. For founders and investors in consumer brands, it is a reminder that heritage alone does not guarantee relevance, and that venture firms are increasingly willing to step into hands-on ownership.
Source: 36Kr




